I thought I’d share this Australian Journal of Pharmacy (AJP) article with you all:
https://ajp.com.au/news/how-many-australians-are-accessing-unapproved-medicinal-cannabis/
Note: Although products that are obtained on the SAS scheme are ones that have not yet been approved by the TGA, their manufacturers would invariably possess at least one GMP licence. GMP licences are recognised globally. A GMP licence is a pre-requisite for SAS listings (i.e. Category A, Category B and Category C).
InX_
I thought I’d share this Australian Journal of Pharmacy (AJP)...
-
- There are more pages in this discussion • 270 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.58M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 3022 | 4 |
View Market Depth
| Last trade - 16.12pm 28/06/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable